G
Giovanni Cammaroto
Researcher at University of Messina
Publications - 113
Citations - 4279
Giovanni Cammaroto is an academic researcher from University of Messina. The author has contributed to research in topics: Medicine & Obstructive sleep apnea. The author has an hindex of 16, co-authored 82 publications receiving 2665 citations.
Papers
More filters
Journal ArticleDOI
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
Jerome R. Lechien,Carlos M. Chiesa-Estomba,Daniele R De Siati,Mihaela Horoi,Serge D Le Bon,Alexandra Rodriguez,Didier Dequanter,Serge Blecic,Fahd El Afia,Lea Distinguin,Younes Chekkoury-Idrissi,Stéphane Hans,Irene Lopez Delgado,Christian Calvo-Henriquez,Philippe Lavigne,Chiara Falanga,Maria Rosaria Barillari,Giovanni Cammaroto,Mohamad Khalife,Pierre Leich,Christel Souchay,Camelia Rossi,Fabrice Journe,Julien Hsieh,Myriam Edjlali,Myriam Edjlali,Robert Carlier,Laurence Ris,Andrea Lovato,Cosimo de Filippis,Frédérique Coppée,Nicolas Fakhry,Tareck Ayad,Sven Saussez +33 more
TL;DR: Olfactory and gustatory disorders are prevalent symptoms in European CO VID-19 patients, who may not have nasal symptoms, and the sudden anosmia or ageusia need to be recognized by the international scientific community as important symptoms of the COVID-19 infection.
Journal ArticleDOI
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019.
Jerome R. Lechien,Carlos M. Chiesa-Estomba,Sammy Place,Yves Van Laethem,Pierre Cabaraux,Quentin Mat,Kathy Huet,Jan Plzak,Mihaela Horoi,Stéphane Hans,Maria Rosaria Barillari,Giovanni Cammaroto,Nicolas Fakhry,Delphine Martiny,Tareck Ayad,Lionel Jouffe,Claire Hopkins,Sven Saussez,Sven Saussez +18 more
TL;DR: The clinical presentation of European patients with mild‐to‐moderate COVID‐19 infection is still unknown and further research is needed to determine the cause of death.
Journal ArticleDOI
Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients.
Jerome R. Lechien,Carlos M. Chiesa-Estomba,Eline Beckers,Vincent Mustin,Morgane Ducarme,Fabrice Journe,Arnaud Marchant,Lionel Jouffe,Maria Rosaria Barillari,Giovanni Cammaroto,Marta P. Circiu,Stéphane Hans,Sven Saussez,Sven Saussez +13 more
TL;DR: In this article, the authors investigated prevalence and recovery of olfactory dysfunction in COVID-19 patients according to the disease severity and found that the prevalence of OD was significantly higher in mild form (85.9%) compared with moderate-to-critical forms (4.5-6.9%).
Journal ArticleDOI
Risk Factors for Obstructive Sleep Apnea Syndrome in Children: State of the Art.
Giampiero Gulotta,Giannicola Iannella,Claudio Vicini,Antonella Polimeni,Antonio Greco,Marco de Vincentiis,Irene Claudia Visconti,Giuseppe Meccariello,Giovanni Cammaroto,Andrea De Vito,Riccardo Gobbi,Chiara Bellini,Elisabetta Firinu,Annalisa Pace,Andrea Colizza,Stefano Pelucchi,Giuseppe Magliulo +16 more
TL;DR: The object of this paper is to analyze the state of the art on this specific topic, discussing its implications in terms of diagnosis and management.
Journal ArticleDOI
Features of Mild-to-Moderate COVID-19 Patients With Dysphonia.
Leman and Meier,Jerome R. Lechien,Carlos M. Chiesa-Estomba,Pierre Cabaraux,Quentin Mat,Kathy Huet,Bernard Harmegnies,Mihaela Horoi,Serge-Daniel Le Bon,Alexandra Rodriguez,Didier Dequanter,Stéphane Hans,Lise Crevier-Buchman,Baptiste Hochet,Lea Distinguin,Younes Chekkoury-Idrissi,Marta P. Circiu,Fahd El Afia,Maria Rosaria Barillari,Giovanni Cammaroto,Nicolas Fakhry,Justin Michel,Thomas Radulesco,Delphine Martiny,Philippe Lavigne,Lionel Jouffe,Géraldine Descamps,Fabrice Journe,Eleonora M C Trecca,Julien Hsieh,Irene Lopez Delgado,Christian Calvo-Henriquez,Sébastien Vergez,Mohamad Khalife,Gabriele Molteni,Giuditta Mannelli,Giovanna Cantarella,Manuel Tucciarone,Christel Souchay,Pierre Leich,Tareck Ayad,Sven Saussez +41 more
TL;DR: Dysphonia may be encountered in a quarter of patients with mild-to-moderate COVID-19 and should be considered as a symptom list of the infection.